Human parainfluenza virus 3 vaccine candidates attenuated by codon-pair deoptimization are immunogenic and protective in hamsters.

Autor: Afroz S; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Saul S; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Dai J; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Surman S; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Liu X; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Park HS; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Le Nouën C; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Lingemann M; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Dahal B; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Coleman JR; Codagenix Inc., Stony Brook, NY 11790., Mueller S; Codagenix Inc., Stony Brook, NY 11790., Collins PL; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Buchholz UJ; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892., Munir S; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 Jun 18; Vol. 121 (25), pp. e2316376121. Date of Electronic Publication: 2024 Jun 11.

Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling.

Autor: Alig SK; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Shahrokh Esfahani M; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Garofalo A; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Li MY; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Rossi C; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA.; Hematology Department, University Hospital F. Mitterrand and Inserm UMR 1231, Dijon, France., Flerlage T; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA., Flerlage JE; Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA., Adams R; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Stanford University, Stanford, CA, USA., Binkley MS; Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA, USA., Shukla N; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Jin MC; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Olsen M; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Telenius A; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Mutter JA; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Schroers-Martin JG; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Sworder BJ; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Rai S; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., King DA; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Schultz A; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Bögeholz J; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Su S; Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA, USA., Kathuria KR; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Liu CL; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Kang X; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Strohband MJ; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Langfitt D; Department of Bone Marrow Transplant and Cellular Therapy, St Jude Children's Research Hospital, Memphis, TN, USA., Pobre-Piza KF; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA., Surman S; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA., Tian F; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Spina V; Laboratory of Molecular Diagnostics, Department of Medical Genetics EOLAB, Bellinzona, Switzerland., Tousseyn T; Department of Imaging and Pathology, KU Leuven, Leuven, Belgium., Buedts L; Department of Human Genetics, KU Leuven, Leuven, Belgium., Hoppe R; Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA, USA., Natkunam Y; Department of Pathology, Stanford University, Stanford, CA, USA., Fornecker LM; Institut de Cancérologie Strasbourg Europe (ICANS) and University of Strasbourg, Strasbourg, France., Castellino SM; Department of Pediatrics, Emory University, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA, USA., Advani R; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Rossi D; Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.; Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland., Lynch R; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Ghesquières H; Department of Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France., Casasnovas O; Hematology Department, University Hospital F. Mitterrand and Inserm UMR 1231, Dijon, France., Kurtz DM; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA., Marks LJ; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Stanford University, Stanford, CA, USA., Link MP; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Stanford University, Stanford, CA, USA., André M; Department of Haematology, Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium., Vandenberghe P; Department of Human Genetics, KU Leuven, Leuven, Belgium.; Department of Hematology, University Hospitals Leuven, Leuven, Belgium., Steidl C; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Diehn M; Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA, USA. diehn@stanford.edu., Alizadeh AA; Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA, USA. arasha@stanford.edu.

Publikováno v: Nature [Nature] 2024 Jan; Vol. 625 (7996), pp. 778-787. Date of Electronic Publication: 2023 Dec 11.

Long lived multi-isotype anti-HIV antibody responses following a prime-double boost immunization strategy

Autor: Stambas, J., Brown, S.A., Gutierrez, A., Sealy, R., Yue, W., Jones, B., Lockey, T.D., Zirkel, A., Freiden, P., Brown, B., Surman, S., Coleclough, C., Slobod, K.S., Doherty, P.C., Hurwitz, J.L. ^*

Publikováno v: In Vaccine 2005 23(19):2454-2464

Human parainfluenza virus type 3 expressing the respiratory syncytial virus pre-fusion F protein modified for virion packaging yields protective intranasal vaccine candidates.

Autor: Liu X; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Liang B; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Liu X; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Amaro-Carambot E; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Surman S; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Kwong PD; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Collins PL; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Munir S; RNA Viruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.

Publikováno v: PloS one [PLoS One] 2020 Feb 11; Vol. 15 (2), pp. e0228572. Date of Electronic Publication: 2020 Feb 11 (Print Publication: 2020).

Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells

Autor: Usherwood, E J, Roy, D J, Ward, K, Surman, S L, Dutia, B M, Blackman, M A, Stewart, J P, Woodland, D L

Publikováno v: Usherwood, E J, Roy, D J, Ward, K, Surman, S L, Dutia, B M, Blackman, M A, Stewart, J P & Woodland, D L 2000, ' Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells ', Journal of Experimental Medicine, vol. 192, no. 7, pp. 943-52 .

The contribution of the latent antigen-specific CD8(+) T cell response to the control of gammaherpesvirus latency is currently obscure. Some latent antigens induce potent T cell responses, but little is known about their induction or the role they pl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3094::fe0388b423bd9b70d475be046e438ba1
https://www.pure.ed.ac.uk/ws/files/10726034/Control_of_Gammaherpesvirus_Latency_by_Latent_Antigen_specific_CD8_T_Cells.pdf